Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study, Journal of Neurology, July 2023, Springer Science + Business Media,
DOI: 10.1007/s00415-023-11820-0.
You can read the full text:

Read

Contributors

The following have contributed to this page